Intrexon Corporation is a privately held life sciences company that employs modular DNA control systems to enhance capabilities, improve safety and lower cost in human therapeutics, protein production, industrial enzymes and ag/bio. The company's advanced transgene engineering platform enables a new level of biotech - combining breakthroughs in DNA control systems with corresponding advancements in modular transgene design, assembly and optimization. The company is currently using these advanced capabilities to undertake foremost challenges across the life sciences spectrum. Company headquarters is located at the Virginia Tech Corporate Research Center in Blacksburg, Va., which is also the primary site for the company's advanced transgene engineering operations. Intrexon Corporation has additional business and R&D operations located in Germantown, Md. and San Francisco.
Partial Data by Infogroup (c) 2024. All rights reserved.